Impact of Granulocyte colony-stimulating factor (filgrastim) on absolute neutrophil count after receiving filgrastim in cancer patients with febrile neutropenia: A 5-year retrospective cohort study. Pharm Pract (Granada) [Internet]. 2025 Oct. 8 [cited 2026 May 27];23(3):1-8. Available from: https://pharmacypractice.org/index.php/pp/article/view/3283